Bookmark and Share

$LXRP DehydraTECH Drug-Delivery Platform May Ease Overdose Risk in Cannabis Edibles

  • Edible cannabis products are absorbed slowly
  • Consumers of cannabis edibles often mistake the delayed effect for insufficiency, leading to overdosing
  • DehydraTECH drug-delivery platform speeds up absorption, reducing overdose risk

Sometimes what is gained on the roundabouts is lost on the swings, to paraphrase an old saying. Cannabis liberalization has introduced an entirely new sector to the food and beverage industry – namely, cannabis edibles such as cookies, chocolates and candies. It’s a sector that appears poised for growth. But as mass consumption increases, a hidden problem is emerging (http://cnw.fm/JwQv3). Because bioabsorption rates via edibles are slower than those via smoking, oral ingestion is leading to unexpected challenges. Consumers mistake the slow onset of effect of traditional cannabis edibles for not enough cannabinoid, so they increase consumption which can lead to overdosing. However, a biotech solution from Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) appears to solve this problem. The company’s DehydraTECH(TM) drug-delivery platform greatly increases the rate at which drugs like cannabis are absorbed by the body. The technology could be used to avoid overdoses before they ever begin.

Consumers have certainly developed a taste for cannabis. A recent report projects the global cannabis-edibles market will reach over $11.6 billion by 2025, climbing at a CAGR of 25 percent, from $2.4 billion in…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]

CBDWire is part of the InvestorBrandNetwork.

Wednesday, November 6th, 2019 Uncategorized